在花粉散射季节对日本香柏花粉过敏的严重程度和预防行为进行比较研究:单中心分析分析
Tatsuya Tai1,2, Masahiro Watanabe3, Sayaka Yamashita2
1Department of Infection Control Service Office, Kagawa University Hospital, Japan.
Journal of public health research
|October 14, 2025
概括
预防性行为显著降低了花草热的严重程度. 早期使用抗胺剂和季前咨询对于日本香柏 (JC) 花粉过敏对于管理症状和改善患者结果至关重要.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 环境健康 环境健康
- 公共卫生 公共卫生
背景情况:
- 全球上升的花粉热病例与全球变暖等因素有关.
- 日本香柏 (JC) 花粉是日本的主要过敏原,导致严重的过敏性鼻炎.
- 患者的预防行为是管理花粉热的关键,但人们对其了解甚少.
研究的目的:
- 调查JC花粉季节症状严重程度和预防行为之间的关系.
- 确定有效的策略来管理由JC花粉引起的过敏性鼻炎.
主要方法:
- 对161名新的JC花粉过敏患者的观察研究.
- 通过采访收集的数据,使用五分级和鼻腔症状得分评估症状严重程度.
- 评估预防行为,包括先发制人的抗胺剂使用,免疫疗法和季前咨询;使用时间序列分析.
主要成果:
- 寻求季前咨询的患者更有可能使用预防性治疗 (p<0.001).
- 没有患有严重症状的患者从事预防行为;只有10.5%的人寻求季前咨询.
- 预防性抗胰岛素使用 (p=0.007) 和季前咨询 (p<0.001) 显著减少了严重病例,严重病例在发病后每天增加6% (p=0.0064).
结论:
- 及早实施预防措施对于减少花粉热症状严重程度至关重要.
- 促进预防行为可以减轻花粉热的经济负担.
- 这些发现支持加强公共卫生战略,以全球管理过敏性鼻炎.
相关概念视频
Allergic Reactions
32.0K
Overview
32.0K
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K


